Sage Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Highlights Pipeline and Business Progress Rolling NDA submission for zuranolone in MDD expected to begin in early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results